KARBE FRANK

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
KARBE FRANK's trades of Phathom Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
21.40
Quantity 750 -0.5%
Value US$16,050
Transaction date
Planned sale
Price
21.50
Quantity 750 -0.5%
Value US$16,125
Transaction date
Planned sale
Price
30.00
Quantity 11,800 -6.7%
Value US$354,000
Transaction date
Planned sale
Price
24.45
Quantity 670 -0.4%
Value US$16,383
Transaction date
Planned sale
Price
23.63
Quantity 380 -0.2%
Value US$8,980
Transaction date
Planned sale
Price
24.00
Quantity 1,500 -0.9%
Value US$36,000
Transaction date
Planned sale
Price
20.00
Quantity 750 -0.5%
Value US$15,000
Transaction date
Planned sale
Price
20.00
Quantity 750 -0.5%
Value US$15,000
Transaction date
Planned sale
Price
21.73
Quantity 750 -0.5%
Value US$16,298
Transaction date
Planned sale
Price
20.01
Quantity 21,150 -11.5%
Value US$423,275
Transaction date
Planned sale
Price
20.04
Quantity 3,650 -2.2%
Value US$73,146
Transaction date
Planned sale
Price
20.00
Quantity 700 -0.4%
Value US$14,000
Transaction date
Purchase
Price
9.10
Quantity 8,000 +inf%
Value US$72,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-13
B Purchase
4,500 +10.9%
107.84
US$3,985,644 		4,500 +10.9% 107.84 US$3,985,644
2023-07-31 2023-07-27
B Purchase
27,829 -25.2%
283.98
US$2,997,331 		27,829 -25.2% 283.98 US$2,997,331
2023-04-12 2023-04-10
B Purchase
43,336 -4.4%
248.18
US$3,058,522 		43,336 -4.4% 248.18 US$3,058,522
2022-09-15 2022-09-15
B Purchase
50,000 +inf%
2.09
US$104,695 		50,000 +inf% 2.09 US$104,695
2021-02-18 2021-02-16
PlS Planned sale
750 -0.5%
21.40
US$16,050 		750 -0.5% 21.40 US$16,050
2021-02-01 2021-01-28
PlS Planned sale
300 -0.2%
24.00
US$7,200 		300 -0.2% 24.00 US$7,200
2021-01-20 2021-01-15
PlS Planned sale
750 -0.5%
21.50
US$16,125 		750 -0.5% 21.50 US$16,125
2020-12-30 2020-12-28
PlS Planned sale
11,800 -6.7%
30.00
US$354,000 		11,800 -6.7% 30.00 US$354,000
2020-12-17 2020-12-15
PlS Planned sale
670 -0.4%
24.45
US$16,383 		670 -0.4% 24.45 US$16,383
2020-12-17 2020-12-15
PlS Planned sale
380 -0.2%
23.63
US$8,980 		380 -0.2% 23.63 US$8,980
2020-12-02 2020-11-30
PlS Planned sale
1,500 -0.9%
24.00
US$36,000 		1,500 -0.9% 24.00 US$36,000
2020-11-19 2020-11-17
PlS Planned sale
750 -0.5%
20.00
US$15,000 		750 -0.5% 20.00 US$15,000
2020-11-17 2020-11-13
PlS Planned sale
750 -0.5%
20.00
US$15,000 		750 -0.5% 20.00 US$15,000
2020-09-17 2020-09-15
PlS Planned sale
750 -0.5%
21.73
US$16,298 		750 -0.5% 21.73 US$16,298
2020-09-01 2020-08-31
PlS Planned sale
21,150 -11.5%
20.01
US$423,275 		21,150 -11.5% 20.01 US$423,275
2020-09-01 2020-08-28
PlS Planned sale
3,650 -2.2%
20.04
US$73,146 		3,650 -2.2% 20.04 US$73,146
2020-08-21 2020-08-19
PlS Planned sale
700 -0.4%
20.00
US$14,000 		700 -0.4% 20.00 US$14,000
2019-06-11 2019-06-11
B Purchase
8,000 +inf%
9.10
US$72,800 		8,000 +inf% 9.10 US$72,800